❌

Normal view

SlideChat is a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types

Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01220-4

Chen et al. have developed SlideChat, a multimodal generative artificial intelligence assistant, which they benchmark on 27 pathology tasks across 33 cancer types. Expert pathologists rated the assistant as clinically relevant and accurate.

Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis

Oncogene, Published online: 31 August 2026; doi:10.1038/s41388-026-03974-8

Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis

Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose

Nature Cancer, Published online: 25 August 2026; doi:10.1038/s43018-026-01241-z

Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose

Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias

Li et al. developed a ferritin aggregation cell engager that helps CAR T cells better recognize and attack leukemia cells without re-engineering the CAR itself. This versatile platform overcomes antigen modulation and enables combination with chemotherapy.

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma

Nature, Published online: 25 March 2026; doi:10.1038/s41586-026-10264-6

Androgen activity in the male embryonic hindbrain prolongs hindbrain differentiation in male individuals and drives sex differences in the incidence and prognosis of posterior fossa type A (PFA) ependymoma, an aggressive childhood brain tumour.

Harnessing pyroptosis in breast cancer therapy: immunological mechanisms and emerging biomaterial strategies

Cell Death Discovery, Published online: 12 March 2026; doi:10.1038/s41420-026-02996-1

Harnessing pyroptosis in breast cancer therapy: immunological mechanisms and emerging biomaterial strategies
❌